Skip to main content

View full-text article in PMC

. 2020 Jul 1;2020:1798147. doi: 10.1155/2020/1798147

Table 3.

Correlations of the serum levels of HMGB1 with percentage of CD14⁺ TREM-1⁺, CD14⁺ TREM-2⁺ monocytes, and TREM-1/TREM-2 ratio.

HMGB1 (all gliomas)				95% CI
	CD14⁺ TREM-1⁺ Mo	Spearman r	-0.272
	CD14⁺ TREM-1⁺ Mo	P	0.049	-0.512 to 0.006
	CD14⁺ TREM-2⁺ Mo	Spearman r	0.369
	CD14⁺ TREM-2⁺ Mo	P	0.007	0.102 to 0.587
	TREM-1/TREM-2 ratio	Spearman r	-0.398
	TREM-1/TREM-2 ratio	P	0.004	-0.611 to -0.132
HMGB1 (G. IV)
	CD14⁺ TREM-1⁺ Mo	Spearman r	-0.479
	CD14⁺ TREM-1⁺ Mo	P	0.016	-0.741 to -0.091
	CD14⁺ TREM-2⁺ Mo	Spearman r	0.363
	CD14⁺ TREM-2⁺ Mo	P	0.075	-0.050 to 0.670
	TREM-1/TREM-2 ratio	Spearman r	-0.516
	TREM-1/TREM-2 ratio	P	0.008	-0.762 to -0.140

GBM: glioblastoma multiforme.